You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

24 Results
Guidelines and Advice
Status: Archived
ID: CED 10
Sep 2008
Guidelines and Advice
Status: Archived
ID: CED 9
Aug 2008
Guidelines and Advice
Status: Archived
ID: CED 8
Jul 2008
Guidelines and Advice
Status: Archived
ID: CED 7
Feb 2008
Guidelines and Advice
Status: Archived
ID: 1-13
Sep 2008
Guidelines and Advice
Status: Archived
ID: 3-19
Feb 2008
Guidelines and Advice
Status: Education and Information
ID: 19-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 16-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 6-14
Dec 2008
Guidelines and Advice
Status: Archived
ID: 6-9
Jan 2008
Statistical Reports
Dec 2008
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Brentuximab Vedotin - Relapsed or Refractory Hodgkin Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
brentuximab vedotin,
bendamustine (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
New
Jan 2026

Pages